| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 09/09/2009 | EP2098246A1 Method for promoting immune response comprising inhibiting cd22 function in b cells |
| 09/09/2009 | EP2097138A2 Assay |
| 09/09/2009 | EP2097107A2 Methods of therapeutic treatment of eyes and other human tissues using an oxygen-enriched solution |
| 09/09/2009 | EP2097082A1 Pharmaceutical composition comprising metadoxine and garlic oil for preventing and treating alcohol-induced fatty liver and steatohepatitis |
| 09/09/2009 | EP2097078A1 Nanoparticles of paclitaxel and albumin in combination with bevacizumab against cancer |
| 09/09/2009 | EP1728508B1 Medicine for prevention or treatment of frequent urination or urinary incontinence |
| 09/09/2009 | EP1523330B1 Vaccine against salmonid rickettsial septicaemia based on arthrobacter cells |
| 09/09/2009 | EP1509621B1 Diagnostic of alzheimer's disease by analysis of il-10 gene polymorphisms |
| 09/09/2009 | EP1458447B1 Combination of cytochome p 450 dependent protease inhibitors |
| 09/09/2009 | EP1409647A4 Composite scaffolds and methods using same for generating complex tissue grafts |
| 09/09/2009 | EP1397355B1 Pyridyl cyanoguanidine compounds |
| 09/09/2009 | EP1392326B1 Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators |
| 09/09/2009 | EP1165096B1 Use of cytidine derivatives for the treatment of leukaemia |
| 09/09/2009 | EP1098962B1 Diacylglycerol acyl transferase proteins |
| 09/09/2009 | EP1033971B1 Combined chemo-immunotherapy with liposomal drugs and cytokines |
| 09/09/2009 | EP0999835B1 Imidazole derivatives as mdr modulators |
| 09/09/2009 | EP0996857B1 Cancer associated nucleic acids and polypeptides |
| 09/09/2009 | CN101528260A Therapeutic agents for irritable bowel syndrome |
| 09/09/2009 | CN101524540A Selective dopamine D4 receptor agonists used for treating sexual disorder |
| 09/09/2009 | CN101524530A The treatment of diabetes |
| 09/09/2009 | CN101524356A Use of dopamine D3 receptor ligands for production of drugs for treating renal function disorders |
| 09/09/2009 | CN101524353A Oral anti-allergy compound pharmaceutical composition |
| 09/09/2009 | CN101524351A Treating infectious diseases by administering an ICE inhibitor |
| 09/09/2009 | CN101524347A Intraocular implant for preventing and treating after cataract and preparation method thereof |
| 09/09/2009 | CN100537770C Von willebrand factor (vWF)-cleaving enzyme |
| 09/09/2009 | CN100537542C Farnesyl protein transferase inhibitors as antitumor agents |
| 09/09/2009 | CN100537527C Aryl and biaryl compounds having MCH modulatory activity |
| 09/09/2009 | CN100536919C Interferon antagon and usage of Flt3L antagon |
| 09/09/2009 | CN100536853C Ss-l-2'-deoxynucleosides for the treatment of resistant HBV strains and combination therapies |
| 09/09/2009 | CN100536852C Application of L-FMAU for preparation of medicament for combination therapies of hepatitis b virus infection |
| 09/09/2009 | CN100536850C Combinations comprising staurosporines |
| 09/09/2009 | CN100536840C Combinations of anti-cancer agents |
| 09/08/2009 | US7586020 Methods for determining effects of maternal treatments on offspring |
| 09/08/2009 | US7585966 Directed against accessible regions in the telomerase ribonucleoprotein; cancer |
| 09/08/2009 | US7585854 Method for treating endometriosis |
| 09/08/2009 | US7585847 Immunostimulatory nucleic acids for the treatment of asthma and allergy |
| 09/08/2009 | US7585841 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase Src |
| 09/08/2009 | US7585523 Oral administering neurotransmitter with plant extract; cognition activators, sleep disorders; hypotensive agents; viricides; central nervous system disorders |
| 09/08/2009 | US7585520 Compositions containing both sedative and non-sedative antihistamines and sleep aids |
| 09/08/2009 | US7585519 Esters of L-carnitine or alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds |
| 09/08/2009 | US7585496 Stable pharmaceutical composition granulocyte-colony stimulating factor |
| 09/08/2009 | CA2478066C Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting |
| 09/08/2009 | CA2463598C Imidazo (4,3-e)-1,2,4-triazolo(1,5-c) pyrimidines as adenosine a2a receptor antagonists |
| 09/08/2009 | CA2442210C Aryl oxime-piperazines useful as ccr5 antagonists |
| 09/08/2009 | CA2387351C Indole derivatives as tyrosine kinase inhibitors |
| 09/08/2009 | CA2360220C Oxadiazole compounds and compositions for delivering active agents |
| 09/08/2009 | CA2329636C Riluzole and levodopa combinations for treating parkinson's disease |
| 09/08/2009 | CA2290745C Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 09/08/2009 | CA2261799C Composition comprising insulin and insulin-like growth factor-i (igf-i) |
| 09/08/2009 | CA2242406C Topoisomerase ii poison and bis-dioxypiperazine derivative combination therapy |
| 09/03/2009 | WO2009108573A1 Combination anti-cancer agents |
| 09/03/2009 | WO2009107766A1 Pharmaceutical composition for transnasal administration |
| 09/03/2009 | WO2009107660A1 Prophylactic or therapeutic agent for diabetes or obesity |
| 09/03/2009 | WO2009107652A1 Agent for enhancing corneal epithelial barrier function |
| 09/03/2009 | WO2009106574A2 Combinations for treating hiv-associated pain |
| 09/03/2009 | WO2009106549A2 Antitumor combination comprising a morpholinyl anthracycline derivative and demethylating agents |
| 09/03/2009 | WO2009106302A1 Use of s-adenosylmethionine (sam) and superoxide dismutase (sod) for the preparation of medicaments for the treatment of alzheimer's disease |
| 09/03/2009 | WO2009087474A3 Agonists for antimicrobial peptide systems |
| 09/03/2009 | WO2009085198A3 Combination of metformin r-(+)-lipoate and antiobesity agents for the treatment of diabetic hyperglycemia and diabetic complications |
| 09/03/2009 | WO2009082818A8 Novel c-21-keto lupane derivatives preparation and use thereof |
| 09/03/2009 | WO2009073683A3 Methods of treating copd |
| 09/03/2009 | US20090221706 Methods of treating cognitive dysfunction by modulating brain energy metabolism |
| 09/03/2009 | US20090221701 Use of fibrates for the preparation of a medicament useful in the treatment of congestive heart failure |
| 09/03/2009 | US20090221686 Modulation of the Transcription of Pro-Inflammatory Gene Products |
| 09/03/2009 | US20090221519 Combinations of receptor tyrosine kinase inhibitor with an a1-acidic glycoprotein binding compound |
| 09/03/2009 | US20090221504 Dose of an angiogenic factor and method of administering to improve myocardial blood flow |
| 09/03/2009 | US20090221472 Method for treating transplant rejection |
| 09/03/2009 | US20090220601 Autologous Oral Grafts |
| 09/03/2009 | US20090220510 Recognize aberrant glycosylated form of the EGFR; evident upon aberrant post-translational modification; cancer |
| 09/03/2009 | US20090220505 Methods of inhibiting amyloid toxicity |
| 09/03/2009 | US20090220467 Use of type ii pneumocytes in the treatment of pulmonary diseases associated with pulmonary fibrosis |
| 09/03/2009 | US20090220459 Non-pathogenic and/or attenuated bacteria capable of inducing apoptosis in macrophages, process of manufacturing and uses thereof |
| 09/03/2009 | US20090220454 Use of the histone deacetylase inhibitor N-hydroxy-4-[2-(3-dimethylaminobenzofuran-2-ylcarbonylamino)ethoxy]benzamide (aka CRA-24781, PCI-24781) for treating myelogenous leukemia (MML) or acute myelogenous leukemia (AML), optionally in combination therapy |
| 09/03/2009 | US20090218731 Shaped body and method for production of said body |
| 09/03/2009 | DE19521720B4 Insulinanalogonformulierungen Insulin analog formulations |
| 09/03/2009 | DE102008011868A1 Combined agent, useful e.g. to treat bone diseases, which are conditioned by increased osteoclastic activity, and osteoporosis, comprises two separate agents such as carboanhydrase-inhibitor and/or H(+)-ATPase inhibitor and parathormone |
| 09/03/2009 | DE102004028899B4 Verwendung einer Kombination zur präventiven und/oder therapeutischen Behandlung von bakteriell bedingten Infektionserkrankungen oder der Sepsis Using a combination of preventive and / or therapeutic treatment of bacterial infectious diseases or sepsis |
| 09/03/2009 | CA2717100A1 Combination anti-cancer agents |
| 09/03/2009 | CA2716893A1 Use of s-adenosylmethionine (sam) and superoxide dismutase (sod) for the preparation of medicaments for the treatment of alzheimer's disease |
| 09/03/2009 | CA2716565A1 Pharmaceutical composition for transnasal administration |
| 09/03/2009 | CA2716405A1 Combinations for treating hiv-associated pain |
| 09/02/2009 | EP2095828A1 Use of S-adenosylmethionine (SAM) and superoxide dismutase (SOD) for the preparation of medicaments for the treatment of Alzeimer's disease |
| 09/02/2009 | EP2095817A1 Therapeutic compositions and methods |
| 09/02/2009 | EP2095814A1 Nicotine withdrawal supported by medication |
| 09/02/2009 | EP2095813A1 Tablet for buccal, sublingual or gingival administration, comprising an effervescent couple |
| 09/02/2009 | EP2094358A2 Imidazoles for treating multi-drug resistant bacterial infections |
| 09/02/2009 | EP2094264A1 Clotrimazol for treating staphylococcal infections |
| 09/02/2009 | EP2094259A1 Renin inhibitors for the prevention and treatment of hypertension in obese patients |
| 09/02/2009 | EP2094257A1 Methods for improving bioavailability of a renin inhibitor |
| 09/02/2009 | EP1904070A4 Dietary supplement for enhancing skeletal muscle mass, decreasing muscle protein degradation, downregulation of muscle catabolism pathways, and decreasing catabolism of muscle cells |
| 09/02/2009 | EP1458392B1 Acridones as inhibitors of impdh enzyme |
| 09/02/2009 | EP1411913A4 Antimicrobial nanoemulsion compositions and methods |
| 09/02/2009 | EP1392349B1 Use of angiotensinogen and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions |
| 09/02/2009 | EP1326584B1 Delivery system and method of treating or preventing otitis media |
| 09/02/2009 | EP1282443B1 Gene detection assay for improving the likelihood of an effective response to an erbb antagonist cancer therapy |
| 09/02/2009 | EP1189645B1 Non-covalent bioconjugates useful for diagnosis and therapy |
| 09/02/2009 | EP1087991B1 Prodrugs of dipeptidyl peptidase iv inhibitors |
| 09/02/2009 | EP0892643B2 Methods for inhibiting an immune response by blocking the gp39/cd40 and ctla4/cd28/b7 pathways and compositions for use therewith |
| 09/02/2009 | CN101522266A Topical skin compositions, their preparation, and their use |
| 09/02/2009 | CN101522265A Topical skin compositions, their preparation and their use |